Confluent, Inc. (CFLT) Financials
Newest figures come from the 10-K for FY2025, filed Feb 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CFLT SEC filings page.
Confluent, Inc. (CFLT) reported $1.2B in revenue for fiscal year 2025, up 21.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Confluent is scaling revenue while losses narrow and cash turns positive, but rising receivables and material debt shape how growth is financed.
The business crossed an important quality threshold: net margin improved from-57.0% in FY2023 to-25.3% in FY2025, while operating cash flow also moved into positive territory. In FY2025, operating cash flow of$64.3M exceeded free cash flow of$60.7M , indicating reported cash generation was not mainly absorbed by capital spending.
Gross margin expanded from
Accounts receivable climbed from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Confluent, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Confluent, Inc. has an operating margin of -32.6%, meaning the company loses $33 on every $100 of revenue. This results in a profitability score of 24/100. This is up from -43.5% the prior year.
Confluent, Inc.'s revenue surged 21.1% year-over-year to $1.2B, reflecting rapid business expansion. This strong growth earns a score of 84/100.
Confluent, Inc. has a moderate D/E ratio of 0.94. This balance of debt and equity financing earns a leverage score of 48/100.
With a current ratio of 3.83, Confluent, Inc. holds $3.83 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.
Confluent, Inc.'s free cash flow margin of 5.2% results in a low score of 28/100. Capital expenditures of $3.6M absorb a large share of operating cash flow.
Confluent, Inc. posts a -25.3% return on equity (ROE), meaning it loses $25 for every $100 of shareholders' equity. This results in a returns score of 34/100. This is up from -35.9% the prior year.
Confluent, Inc. scores 3.35, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($11.1B) relative to total liabilities ($1.8B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Confluent, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Confluent, Inc. reported a net loss of $295.3M while generating $64.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Confluent, Inc. generated $314.8M in revenue in Q4 2025. This represents an increase of 20.5% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.
Confluent, Inc.'s EBITDA was -$90.7M in Q4 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.8% from the same quarter a year earlier. Against the prior quarter it is down 21.1%.
Confluent, Inc. reported -$79.2M in net income in Q4 2025. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 19.2%.
Confluent, Inc. earned -$0.23 per diluted share (EPS) in Q4 2025. This represents an increase of 14.8% from the same quarter a year earlier. Against the prior quarter it is down 21.1%.
Cash & Balance Sheet
Confluent, Inc. generated $41.7M in free cash flow in Q4 2025, representing cash available after capex. This represents an increase of 20.6% from the same quarter a year earlier. Against the prior quarter it is up 38.9%.
Confluent, Inc. held $347.2M in cash against $1.1B in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Margins & Returns
Confluent, Inc.'s gross margin was 74.7% in Q4 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.
Confluent, Inc.'s operating margin was -31.5% in Q4 2025, reflecting core business profitability. This is up 9.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.6 percentage points.
Confluent, Inc.'s net profit margin was -25.2% in Q4 2025, showing the share of revenue converted to profit. This is up 8.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.
Confluent, Inc.'s ROE was -6.8% in Q4 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Capital Allocation
Confluent, Inc. invested $121.9M in research and development in Q4 2025. This represents an increase of 6.1% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.
Confluent, Inc. invested $442K in capex in Q4 2025, funding long-term assets and infrastructure. This represents a decrease of 33.9% from the same quarter a year earlier. Against the prior quarter it is down 45.2%.
Not reported for Q4 2025.
CFLT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $314.8M+20.5% | $298.5M+19.3% | $282.3M+20.1% | $271.1M+24.8% | $261.2M+22.5% | $250.2M+25.0% | $235.0M+24.1% | $217.2M+24.6% |
| Cost of Revenue | $79.7M+17.9% | $77.0M+20.8% | $74.2M+14.1% | $69.1M+12.9% | $67.6M+18.4% | $63.7M+12.7% | $65.0M+12.2% | $61.2M+5.3% |
| Gross Profit | $235.2M+21.4% | $221.6M+18.8% | $208.1M+22.4% | $202.0M+29.5% | $193.7M+24.0% | $186.5M+29.8% | $170.0M+29.4% | $156.0M+34.3% |
| R&D Expenses | $121.9M+6.1% | $121.8M+18.5% | $121.2M+14.3% | $116.8M+19.7% | $114.9M+32.1% | $102.7M+12.6% | $106.1M+23.8% | $97.6M+14.9% |
| SG&A Expenses | $52.6M+33.6% | $40.3M+2.1% | $39.7M+0.7% | $40.1M+4.4% | $39.4M+15.9% | $39.5M+23.8% | $39.4M+8.5% | $38.4M+8.7% |
| Operating Income | -$99.2M+6.2% | -$83.3M+11.1% | -$96.4M+11.0% | -$101.2M+9.1% | -$105.8M-24.9% | -$93.7M+13.8% | -$108.3M+9.2% | -$111.4M+33.0% |
| EBITDA | -$90.7M+7.8% | -$74.9M+15.4% | -$90.3M+12.3% | -$94.6M+11.6% | -$98.4M-22.1% | -$88.6M+15.8% | -$103.0M+11.3% | -$107.0M+34.3% |
| Income Tax | -$393K-125.2% | $1.6M-47.8% | $6.6M+94.5% | -$13.2M-635.0% | $1.6M-95.0% | $3.0M+89.9% | $3.4M+104.2% | $2.5M+49.7% |
| Net Income | -$79.2M+10.0% | -$66.5M+10.3% | -$82.0M+8.8% | -$67.6M+27.3% | -$88.1M+6.4% | -$74.1M+20.0% | -$89.9M+13.1% | -$93.0M+39.1% |
| EPS (Basic) | -$0.23+14.8% | -$0.19+17.4% | -$0.24+14.3% | -$0.20+33.3% | -$0.27+10.0% | -$0.23+23.3% | -$0.28+20.0% | -$0.30+42.3% |
| EPS (Diluted) | -$0.23+14.8% | -$0.19+17.4% | -$0.24+14.3% | -$0.20+33.3% | -$0.27+10.0% | -$0.23+23.3% | -$0.28+20.0% | -$0.30+42.3% |
| Diluted Shares (Avg) | N/A | 346M+6.7% | 341M+6.8% | 336M+6.9% | N/A | 324M+6.7% | 319M+7.2% | 314M+7.7% |
Not reported in any period shown, so not listed: Interest Expense.
CFLT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.0B+10.8% | $2.9B+10.3% | $2.8B+11.4% | $2.7B+10.6% | $2.7B+9.5% | $2.6B+10.4% | $2.5B+8.6% | $2.4B+6.4% |
| Current Assets | $2.6B+10.9% | $2.5B+10.3% | $2.4B+5.8% | $2.3B+5.2% | $2.4B+4.4% | $2.3B+4.5% | $2.3B+7.8% | $2.2B+5.3% |
| Cash & Equivalents | $347.2M-10.0% | $298.5M-7.5% | $295.6M-5.1% | $278.6M-17.2% | $386.0M+10.4% | $322.6M+1.8% | $311.3M-0.4% | $336.4M-2.1% |
| Short-Term Investments | $1.7B+11.9% | $1.7B+10.0% | $1.6B+1.6% | $1.6B+4.3% | $1.5B-1.7% | $1.5B-1.2% | $1.6B+5.5% | $1.6B+4.3% |
| Accounts Receivable | $390.8M+24.3% | $356.4M+27.9% | $357.6M+38.9% | $297.9M+49.0% | $314.3M+36.7% | $278.7M+52.1% | $257.5M+36.4% | $199.8M+17.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $164.4M0.0% | $164.4M0.0% | $164.4M+216.2% | $164.4M+216.2% | $164.4M+216.2% | $164.4M+277.9% | $52.0M+19.5% | $52.0M+19.5% |
| Total Liabilities | $1.8B+4.8% | $1.8B+5.0% | $1.8B+6.0% | $1.7B+5.0% | $1.7B+5.0% | $1.7B+6.4% | $1.7B+5.6% | $1.6B+3.0% |
| Current Liabilities | $680.6M+15.5% | $622.6M+16.4% | $612.9M+17.8% | $529.9M+20.6% | $589.2M+21.0% | $535.0M+22.8% | $520.2M+22.9% | $439.2M+9.5% |
| Non-Current Liabilities | $1.1B-0.8% | $1.1B-0.3% | $1.1B+0.6% | $1.1B-1.0% | $1.1B-1.6% | $1.1B+0.1% | $1.1B-0.7% | $1.2B+0.7% |
| Long-Term Debt | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% | $1.1B+0.4% |
| Total Equity | $1.2B+21.6% | $1.1B+19.8% | $1.1B+21.7% | $1.0B+21.3% | $961.2M+18.6% | $934.3M+18.4% | $873.9M+14.8% | $845.2M+13.5% |
| Retained Earnings | -$2.3B-14.8% | -$2.2B-16.0% | -$2.1B-17.1% | -$2.1B-18.4% | -$2.0B-21.0% | -$1.9B-22.7% | -$1.8B-25.4% | -$1.7B-28.3% |
Not reported in any period shown, so not listed: Inventory.
CFLT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $42.1M+19.6% | $30.8M+97.3% | $18.1M+110.9% | -$26.8M-3.1% | $35.2M+187.8% | $15.6M+272.3% | $8.6M+129.6% | -$26.0M+66.6% |
| Depreciation & Amortization | $7.8M+24.9% | $8.4M+64.7% | $6.1M+15.1% | $6.6M+53.2% | $6.2M+58.9% | $5.1M+45.7% | $5.3M+65.6% | $4.3M+38.1% |
| Stock-Based Compensation | N/A | $101.1M+2.9% | $102.0M+2.9% | $92.6M-2.9% | N/A | $98.3M+9.8% | $99.1M+7.5% | $95.3M+20.2% |
| Capital Expenditures | $442K-33.9% | $807K+32.9% | $919K-16.8% | $1.4M+668.3% | $669K-40.1% | $607K+67.2% | $1.1M+36.6% | $186K-65.9% |
| Free Cash Flow | $41.7M+20.6% | $30.0M+99.9% | $17.2M+129.7% | -$28.2M-7.8% | $34.5M+210.7% | $15.0M+259.2% | $7.5M+125.1% | -$26.1M+66.6% |
| Investing Cash Flow | -$17.8M-273.3% | -$46.8M-113.2% | -$8.5M+81.8% | -$112.0M-568.1% | $10.2M+26.6% | -$21.9M-90.4% | -$46.5M-60.8% | -$16.8M+68.1% |
| Financing Cash Flow | $24.6M+25.9% | $19.8M+14.9% | $6.1M-53.7% | $30.8M+2.7% | $19.5M+77.7% | $17.2M-34.3% | $13.1M-52.4% | $30.0M-20.5% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CFLT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.7%+0.6pp | 74.2%-0.3pp | 73.7%+1.4pp | 74.5%+2.7pp | 74.1%+0.9pp | 74.5%+2.8pp | 72.4%+3.0pp | 71.8%+5.2pp |
| Operating Margin | -31.5%+9.0pp | -27.9%+9.5pp | -34.2%+11.9pp | -37.3%+13.9pp | -40.5%-0.8pp | -37.4%+16.8pp | -46.1%+17.0pp | -51.3%+44.0pp |
| Net Margin | -25.2%+8.5pp | -22.3%+7.4pp | -29.0%+9.2pp | -24.9%+17.9pp | -33.7%+10.4pp | -29.6%+16.7pp | -38.3%+16.4pp | -42.8%+44.7pp |
| Return on Equity | -6.8%+2.4pp | -5.9%+2.0pp | -7.7%+2.6pp | -6.6%+4.4pp | -9.2%+2.5pp | -7.9%+3.8pp | -10.3%+3.3pp | -11.0%+9.5pp |
| Return on Assets | -2.6%+0.6pp | -2.3%+0.5pp | -2.9%+0.6pp | -2.5%+1.3pp | -3.3%+0.5pp | -2.8%+1.1pp | -3.6%+0.9pp | -3.8%+2.8pp |
| Current Ratio | 3.83-0.2x | 4.01-0.2x | 3.98-0.5x | 4.42-0.6x | 3.99-0.6x | 4.24-0.7x | 4.44-0.6x | 5.07-0.2x |
| Debt-to-Equity | 0.94-0.2x | 0.98-0.2x | 1.03-0.2x | 1.07-0.2x | 1.14-0.2x | 1.17-0.2x | 1.25-0.2x | 1.29-0.2x |
| Asset Turnover | 0.110.0x | 0.100.0x | 0.100.0x | 0.100.0x | 0.100.0x | 0.100.0x | 0.090.0x | 0.090.0x |
| FCF Margin | 13.2%0.0pp | 10.1%+4.1pp | 6.1%+2.9pp | -10.4%+1.6pp | 13.2%+8.0pp | 6.0%+10.7pp | 3.2%+19.0pp | -12.0%+32.9pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Confluent, Inc. CFLT | FY2025 | $1.2B | -$295.3M | -25.3% | $11.1B | 51/100 |
| Varonis Systems, Inc. VRNS | FY2025 | $623.5M | -$129.3M | -20.7% | $5.6B | 54/100 |
| WEX Inc. WEX | FY2025 | $2.7B | $304.1M | 11.4% | $6.3B | 55/100 |
| Informatica Inc. INFA | FY2024 | $1.6B | $9.9M | 0.6% | $7.6B | 48/100 |
| UiPath, Inc. PATH | FY2026 | $1.6B | $282.3M | 17.5% | $7.0B | 57/100 |
| SentinelOne, Inc. S | FY2026 | $1.0B | -$450.7M | -45.0% | $7.7B | 45/100 |
Where Confluent, Inc. Ranks
Frequently Asked Questions
What is Confluent, Inc.'s annual revenue?
Confluent, Inc. (CFLT) reported $1.2B in total revenue for fiscal year 2025. This represents a 21.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Confluent, Inc.'s revenue growing?
Confluent, Inc. (CFLT) revenue grew by 21.1% year-over-year, from $963.6M to $1.2B in fiscal year 2025.
Is Confluent, Inc. profitable?
No, Confluent, Inc. (CFLT) reported a net income of -$295.3M in fiscal year 2025, with a net profit margin of -25.3%.
What is Confluent, Inc.'s EBITDA?
Confluent, Inc. (CFLT) had EBITDA of -$350.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Confluent, Inc. have?
As of fiscal year 2025, Confluent, Inc. (CFLT) had $347.2M in cash and equivalents against $1.1B in long-term debt.
What is Confluent, Inc.'s gross margin?
Confluent, Inc. (CFLT) had a gross margin of 74.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Confluent, Inc.'s operating margin?
Confluent, Inc. (CFLT) had an operating margin of -32.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Confluent, Inc.'s net profit margin?
Confluent, Inc. (CFLT) had a net profit margin of -25.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Confluent, Inc.'s return on equity (ROE)?
Confluent, Inc. (CFLT) has a return on equity of -25.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Confluent, Inc.'s free cash flow?
Confluent, Inc. (CFLT) generated $60.7M in free cash flow during fiscal year 2025. This represents a 96.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Confluent, Inc.'s operating cash flow?
Confluent, Inc. (CFLT) generated $64.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Confluent, Inc.'s total assets?
Confluent, Inc. (CFLT) had $3.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Confluent, Inc.'s capital expenditures?
Confluent, Inc. (CFLT) invested $3.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Confluent, Inc. spend on research and development?
Confluent, Inc. (CFLT) invested $481.7M in research and development during fiscal year 2025.
What is Confluent, Inc.'s current ratio?
Confluent, Inc. (CFLT) had a current ratio of 3.83 as of fiscal year 2025, which is generally considered healthy.
What is Confluent, Inc.'s debt-to-equity ratio?
Confluent, Inc. (CFLT) had a debt-to-equity ratio of 0.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Confluent, Inc.'s return on assets (ROA)?
Confluent, Inc. (CFLT) had a return on assets of -9.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Confluent, Inc.'s Altman Z-Score?
Confluent, Inc. (CFLT) has an Altman Z-Score of 3.35, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Confluent, Inc.'s Piotroski F-Score?
Confluent, Inc. (CFLT) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Confluent, Inc.'s earnings high quality?
Confluent, Inc. (CFLT) reported a net loss of $295.3M while generating $64.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Confluent, Inc.?
Confluent, Inc. (CFLT) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.